drugset / Trial / NCT06754085
Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
In this study, 18F-Florastamin PET/CT will be performed in patients with suspected recurrence of prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging.
Timeline
- Start
- 2024-12-19
- Primary completion
- 2026-01-01
- Completion
- 2026-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Florastamin[18F] | Diagnostic / imaging agent | 259 mbq | Intravenous |